ONCTERNAL THERAPEUTICS INC has a total of 43 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ASANA BIOSCIENCES LLC, GLACTONE PHARMA DEV AB and DAE WOONG PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | Australia | 3 | |
#4 | China | 3 | |
#5 | Republic of Korea | 3 | |
#6 | Taiwan | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | Canada | 2 | |
#9 | Mexico | 2 | |
#10 | EAPO (Eurasian Patent Organization) | 1 | |
#11 | Israel | 1 | |
#12 | Japan | 1 | |
#13 | New Zealand | 1 | |
#14 | Philippines | 1 | |
#15 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Jessen Katayoun | 11 |
#2 | Lannutti Brian | 11 |
#3 | Breitmeyer James Bradley | 10 |
#4 | Vernier Jean-Michel | 9 |
#5 | Webber Stephen E | 9 |
#6 | Narayanan Ramesh | 5 |
#7 | Dalton James T | 5 |
#8 | Miller Duane D | 4 |
#9 | Ponnusamy Thamarai | 3 |
#10 | Jean-Michel Vernier | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020028593A1 | A method of treating er mutant expressing breast cancers with selective androgen receptor modulators (sarms) | |
AU2019271382A1 | Selective androgen receptor degrader (SARD) ligands and methods of use thereof | |
SG11201811661TA | Uses of indolinone compounds | |
KR20180123569A | Indolin analogs and uses thereof | |
MX2017003589A | Indolinone compounds and uses thereof. | |
EP3139919A1 | Compounds for treatment of cancer | |
EP2872482A2 | A method of treating breast cancers with selective androgen receptor modulator (sarm) |